Waters Cites Europe, Pharma Slowdown For Q1 3 Percent Organic Revenue Growth | GenomeWeb

With a revenue increase of 5 percent on sales of $268.3 million for the quarter ending March 31 — boosted 2 percent by currency-exchange benefits — mass spec instrument maker Waters this week confirmed the sales slowdown in Europe it had warned about in early April.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.